Bittersweet Phase 3 Keytruda data hits one of two goals in extensive stage small cell lung cancer
January 7, 2020Manufacturing and Production, Research and Development MSD, keytruda
MSD has lifted the curtain on new Phase 3 data on the efficacy of its blockbuster immunotherapy Keytruda, in combination …
Teva to settle bribery lawsuit with $54 million payout
January 7, 2020Manufacturing and Production, Sales and Marketing Teva, bribery, pharma
Israeli drug firm Teva has agreed to settle an ongoing lawsuit levying allegations of the company’s bribery of doctors, it …
Merck, Novartis and Allergan to raise US drug prices, following most of drug industry
January 6, 2020Manufacturing and Production Allgeran, Big Pharma, Merck, Novartis, drug, drug prices
Following most of the large pharmaceutical companies, Merck, Novartis and Allergan have chosen to raise their drug prices. Novartis is …
MHRA expands approval of Dysport for symptomatic treatment of focal spasticity of the upper limbs in paediatric cerebral palsy
January 6, 2020Sales and Marketing Dysport, MHRA, ipsen, pharma
Ipsen has secured an expansion in the UK to the existing label for Dysport (lemborexant), with the Medicines and Healthcare …
FDA gives a priority review for key heart failure drug Farxiga
January 6, 2020Sales and Marketing AstraZeneca, Heart Failures, farxiga
The FDA has accepted a New Drug Application (sNDA) and has granted a priority review for AstraZeneca’s drug Farxiga (dapagliflozin) …
Mysterious viral pneumonia infects dozens in central China, bird flu and SARS ruled out
January 6, 2020Sales and Marketing Bird Flu, China, Sars, WHO, World Health Organisation, Wuhan, pneumonia
A total of 59 cases of viral pneumonia have been reported in the city of Wuhan, with seven people in …
Incyte’s drug stumbles at Phase 3 in treatment-naive acute graft-versus-host disease
January 6, 2020Research and Development, Sales and Marketing Incyte, pharma, trial failure
Drugmaker Incyte has made it known that its selective JAK1 inhibitor therapy itacitinib fell short at Phase 3 in the …
AstraZeneca’s drug Lokelma approved in China
January 6, 2020Sales and Marketing AstraZeneca, China, FDA, eu commission, kidney failure, potassium
AstraZeneca’s Lokelma has been approved by the National Medical Products Administration in China. This is due to positive results based …
Novo Nordisk to offer US patient’s in immediate need free insulin
January 3, 2020Medical Communications Novo, Novo Nordisk, Type 1 diabetes, diabetes, insulin, type 2 diabetes
Novo Nordisk said it would offer free, one-time supply of insulin to those in need, amidst rising insulin prices. Novo …
Single cycle of chemo is just as effective as two in treating testicular cancer, study finds
January 3, 2020Medical Communications Cancer, Men's Cancer, chemo, chemotherapy, testicular cancer
A new study shows that testicular cancer can be successfully treated with less rounds of chemotherapy. The recent study, published …
NICE rules against the use of Akcea’s Waylivra in the NHS
January 3, 2020Medical Communications Akcea, European Commission, FCS, NHS, NICE
NICE has not recommended Akcea’s drug Waylivra (volanesorsen) to be used for the treatment of Familial Chylomicronaemia Syndrome (FCS) in …
Johnson & Johnson sued by Washington State for role in the opioid crisis
January 3, 2020Medical Communications Bernie Sanders, Johnson & Johnson, OxyContin, fentanyl, opioid crisis, opioids
The state of Washington sued pharmaceutical company Johnson & Johnson for deceptive marketing that said their opioids were effective for …
FDA approves artificial pancreas developed by the University of Virginia
January 2, 2020Business Services, Medical Communications FDA, Pancreas, Type 1 diabetes, diabetes, insulin, type 2 diabetes
The FDA has approved an artificial pancreas system based on technology from the University of Virginia’s Center for Diabetes Technology. …
AI is more accurate than doctors at diagnosing breast cancer, study finds
January 2, 2020Business Services AI, AI Cancer, AI Trials, AI diagnoses, AI in clinical trials, Cancer, breast cancer
A recent study showed that Artificial Intelligence is more accurate than doctors in diagnosing breast cancer from mammograms. The research …
China approves 13-valent pneumonia vaccine
January 2, 2020Business Services Chinese Pharma, Pneumonia China, pneumonia, pneumonia vaccine
China’s National Medical Products Administration (NMPA) has approved the launch of the country’s first self-developed 13-valent pneumonia vaccine to protect …
Pfizer, Sanofi and GlaxoSmithKline plan to increase US drug prices in 2020
January 2, 2020Business Services Bernie Sanders, President trump, Presidential Election, Trump, Trump Drugs, drug prices
Multiple drugmakers, including Pfizer, Sanofi and GlaxoSmithKline, plan to increase US list prices on more than 200 drugs in the …
FDA fuelled opioid crisis by failing to police pharmaceutical companies, new study shows
January 2, 2020Business Services FDA, Opioids Crisis, Opioids Trump, OxyContin, Trump Administration, opioids
The FDA’s Risk Evaluation and Mitigation Strategy (REMS), which began in 2012, failed to successfully police the companies creating opioids …
European Commission authorises Janssen’s anti-depressant Spravato
December 23, 2019Sales and Marketing Janssen, MDD, Nasal Spray, TRD, depression, mental health
The European Commission has approved Janssen’s nasal spray Spravato (esketamine), which is used to treat major depressive disorder (MDD) that …
AstraZeneca’s triple combination therapy for patients with COPD approved in China
December 23, 2019Sales and Marketing AstraZeneca, COPD, China, respiration
AstraZeneca has announced that budesonide-glycopyrroniunm-formoterol fumarate has been approved in China for the maintenance treatment of chronic obstructive pulmonary disease …
NHS to fast track cannabis-based treatment for epilepsy
December 23, 2019Sales and Marketing CBD, CBD Oil, cannabis, drug treatment, epilepsy, thc
The NHS has fast-tracked the drug Epidyolex, a cannabidiol (CBD), to be available for epilepsy treatment through the NHS in …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
